CareScience Mortality Risk Model

Presentations from a November 2008 meeting to discuss issues related to mortality measures.

Calibration Data

Description of Facilities in 2008 Calibration DatasetQuantity
FacilitiesN=617
Regions 
Midwest169 (27.44%)
Northeast70 (11.36%)
South274 (44.48%)
West103 (16.72%)
Teaching Status 
Teaching286 (46.8%)
Non-Teaching325 (53.2%)
Bed-size 
<100 beds134 (21.9%)
100-200 beds133(21.8%)
201-300 beds119 (19.5%)
301-400 beds90 (14.7%)
401-500 beds39 (6.4%)
500-600 beds25 (4.1%)
>600 beds71 (11.6%)
Average bed-size293 Beds
Discharges 
Average # of discharge22,414
Total Discharges14,454,473


DiagDescription% CasesMortalityMorbidityComplications
RateFactorsFITRateFactorsFITRateFactorsFIT
008Infct, intestinal d/t oth organisms0.48%1.7%240.0949.9%390.49230.5%370.388
038 Septicemia1.42%18.2%580.22331.5%690.67064.7%760.459
042 HIV disease0.16%7.0%220.18425.3%350.35647.9%340.305
151 Neoplasm, Malignant, stomach0.06%9.4%290.19522.0%350.32458.4%330.301
153 Neoplasm, Malignant, colon0.29%4.6%470.15221.5%450.38950.7%510.345
154 Neoplasm, Malignant, rectum/anus0.12%3.5%340.12213.4%380.42648.5%490.314
157 Neoplasm, Malignant, pancreas0.10%11.1%300.18914.3%280.37349.4%350.320
162 Neop, mlig, trachea/bronchus/lung0.43%12.3%400.20824.7%400.26749.3%450.319
174 Neoplasm, Malignant, female breast0.21%2.1%290.2372.7%280.36715.9%370.277
182 Neoplasm, Malignant, body, uterus0.11%1.2%230.1296.4%250.45833.8%270.298
183 Neop, mlig, ovary/uterine adnexa0.08%5.2%220.21111.8%290.42347.5%370.330
185 Neoplasm, Malignant, prostate0.25%1.1%240.2205.5%220.21723.3%330.280
188 Neoplasm, Malignant, bladder0.10%3.3%270.14312.1%350.50041.0%340.415
189 Neop, Mlig, kdny/oth urinary organ0.13%2.2%320.14010.2%280.47341.1%370.342
191 Neoplasm, Malignant, brain0.09%4.6%240.1707.0%280.40734.8%300.371
197 Neoplasm, metastatic, rsprt/dgstv0.35%13.0%420.14815.4%350.36244.6%480.384
198 Neoplasm, Metastatic, other sites0.29%7.3%360.1239.5%360.36939.6%560.384
202 Neop, mlig,lymphoid/
histiocytic
0.09%10.7%280.19416.9%330.42049.5%360.368
250 Diabetes mellitus1.29%0.9%310.07810.4%610.61137.6%680.431
276 Dsord, fluid/elctrlyt/
acid-base bal
1.17%2.0%340.0758.4%500.53536.5%520.357
280 Anemias, iron deficiency0.19%0.5%140.0404.6%250.30535.6%330.222
282 Anemias, hereditary hemolytic0.20%0.4%130.0566.4%220.41230.2%270.247
285 Anemia, other & unspecified0.20%1.3%230.0415.8%320.33237.8%360.248
288 Diseases of white blood cells0.13%2.3%220.0917.9%350.34546.9%380.326
295 Disorders, schizophrenic0.71%0.0%140.0031.0%270.28314.3%480.220
296 Psychoses, affective1.82%0.0%180.0021.0%380.29913.9%590.250
304 Dependence, drug0.18%0.0%110.0230.6%210.2299.9%390.236
331 Degeneration, other cerebral0.21%2.0%280.1296.1%310.40935.7%440.325
345 Epilepsy0.18%1.1%180.0969.7%170.55231.0%460.437
348 Brain conditions, other0.14%7.7%300.39216.4%350.58650.4%500.457
398 Disease, other rheumatic heart0.10%4.7%180.12516.3%220.32149.7%340.265
401 Hypertension, essential0.24%0.3%170.0624.2%340.48839.3%300.199
410 Acute myocardial infarction1.86%5.9%470.23129.4%680.60054.7%760.433
411 Disease, other acute ischemic heart0.10%0.4%120.0367.5%390.44026.2%310.358
413 Angina pectoris0.05%0.1%100.0112.3%110.21421.0%230.247
414 Disease, oth chronic ischemic heart3.26%0.6%360.0769.6%480.36934.9%640.386
415 Disease, acute pulmonary heart0.42%3.6%270.20416.0%350.50545.6%460.350
424 Diseases, endocardium, other0.21%3.4%240.17928.0%440.32462.8%480.345
425 Cardiomyopathy0.08%2.5%320.2336.0%330.31530.6%310.297
426Disorder, conduction0.16%1.5%350.12511.9%320.58533.2%490.413
427Dysrhythmias, cardiac1.92%2.1%380.4368.9%490.62930.9%610.401
428Failure, heart2.57%3.4%490.11114.4%490.44454.3%590.335
430Hemorrhage, subarachnoid0.08%23.1%290.36131.1%290.50657.9%340.444
431Hemorrhage, intracerebral0.20%28.0%310.34027.4%370.46756.0%420.358
432Hemorrhage, intracranial0.09%16.0%240.35020.0%310.48749.5%410.416
433Oclsn/stenosis, precerebral artery0.51%1.2%160.1465.2%410.33725.5%530.308
434Occlusion, cerebral arteries1.04%5.7%340.16312.6%440.48243.6%500.376
435Ischemia, transient cerebral0.48%0.2%150.0102.7%330.28125.4%400.280
436Disease, acute cerbvas, ill-defined0.01%5.8%120.1625.7%100.41332.8%130.359
440Atherosclerosis0.47%1.8%340.12410.6%460.55036.5%580.359
441Aneurysm and dissection, aortic0.22%8.8%420.28123.2%480.49852.2%730.405
444Embolism and thrombosis, arterial0.10%4.0%310.16715.4%390.53644.5%490.376
453Embolism/thrombosis, venous, other0.38%1.0%240.0548.0%390.44931.5%470.385
458Hypotension0.27%1.9%230.1457.5%300.37844.9%400.246
466Bronchitis and bronchiolitis, acute0.40%0.1%150.0357.7%220.05423.4%280.174
480Pneumonia, viral0.05%0.8%140.1056.7%220.44627.6%250.336
481Pneumonia d/t pneumococcal virus0.06%2.8%190.14116.2%300.55351.4%290.317
482Pneumonia, other bacterial0.23%6.6%350.11422.9%470.40961.2%480.314
486Pneumonia, organism NOS2.16%3.5%340.09610.9%460.44146.9%570.299
491Bronchitis, chronic1.13%1.9%350.07416.0%440.43645.8%510.289
493Asthma0.95%0.3%240.1049.7%350.12627.3%440.199
496Obstruction, chronic airway NEC0.04%7.4%190.32015.6%190.46147.1%310.309

Return to Article Contents
Proceed to Next Section

 

Current as of March 2009
Internet Citation: CareScience Mortality Risk Model. March 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/mortality/KrochMort2.html